- Robert Preidt
- Posted April 13, 2021
FDA Approves First AI Tool to Boost Colonoscopy Accuracy
TUESDAY, April 13, 2021 (HealthDay News) --The first device that uses artificial intelligence (AI) to help detect possible signs of colon cancer during colonoscopy has been approved by the U.S. Food and Drug Administration.
The GI Genius uses AI-based machine learning to help identify lesions such as polyps or suspected tumors in real time during a colonoscopy, according to the agency.
"Artificial intelligence has the potential to transform health care to better assist health care providers and improve patient care. When AI is combined with traditional screenings or surveillance methods, it could help find problems early on, when they may be easier to treat," said Courtney Lias, acting director of the GastroRenal, ObGyn, General Hospital and Urology Devices Office in the FDA's Center for Devices and Radiological Health.
She noted that studies show missed lesions during colon cancer screenings can be a problem even for well-trained clinicians.
"With the FDA's authorization of this device ..., clinicians now have a tool that could help improve their ability to detect gastrointestinal lesions they may have missed otherwise," she added in an agency news release.
The FDA's recent approval of the device is based on an Italian study that included 700 people between the ages of 40 and 80 who had colonoscopies with or without the use of GI Genius.
Colonoscopy plus GI Genius identified lab-confirmed adenomas or carcinomas in 55.1% of patients, compared to 42% with standard colonoscopy, according to the FDA.
The device includes hardware and software that highlights areas of the colon where a potential lesion is detected. During a colonoscopy, the software uses AI algorithm techniques to identify areas that may require further assessment, including closer visual inspection, tissue sampling, testing or removal, or ablation (burning) of the lesion.
The GI Genius is compatible with many standard video endoscopy systems.
Colon cancer is the third-leading cause of cancer death in the United States, according to the National Institutes of Health. Colon cancer usually starts from polyps or other precancerous growths.
Colonoscopies are performed as part of a colon cancer screening plan to detect changes or abnormalities in the lining of the colon and rectum.
The American College of Surgeons has more on colonoscopy.
SOURCE: U.S. Food and Drug Administration, news release, April 9, 2021
Health News is provided as a service to Duren's Clinic Pharmacy site users by HealthDay. Duren's Clinic Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2022 HealthDay All Rights Reserved.